Testing effectiveness (Phase 2)Looking for participantsNCT07185256
What this trial is testing
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
Who this might be right for
ARBBVMDAutosomal-Dominant Bestrophinopathy+1 more
Opus Genetics, Inc 10